Korro Bio, Inc.
KRRO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703647
In the last 90 days, Korro Bio, Inc. insiders filed 1 open-market purchase and 7 sales; 106 institutions reported holding it in 13F filings for Q2 2026, worth $190.1M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Korro Bio, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 84 | 86 | +2 |
| Shares | 17.7M | 15.9M | −1.85M (−10.5%) |
| Value | $90.2M | $33.1M | −$57.1M (−63.3%) |
New holders (22)
Institutions that held Korro Bio, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (20)
Institutions that held Korro Bio, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Lombard Odier Asset Management (Switzerland) SA | 707,071 | $3.63M |
| Voloridge Investment Management, LLC | 76,450 | $392.0K |
| Laurion Capital Management LP | 69,348 | $356.0K |
| Anson Funds Management LP | 42,534 | $218.0K |
| Granahan Investment Management Inc | 39,346 | $202.0K |
| Nomura Holdings Inc | 34,360 | $181.0K |
| Walleye Trading LLC | 27,069 | $139.0K |
| EMC Capital Management | 27,029 | $139.0K |
| Virtu Financial LLC | 25,010 | $128.0K |
| Citadel Advisors LLC | 20,652 | $106.0K |
| Squarepoint Ops LLC | 20,611 | $106.0K |
| ProShare Advisors LLC | 11,861 | $61.0K |
| SG Americas Securities, LLC | 10,137 | $52.0K |
| Group One Trading, L.P. | 1,796 | $9.00K |
| Quadrant Capital Group LLC | 1,830 | $9.00K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 1,568 | $8.00K |
| Eaton Vance Management | 1,000 | $5.00K |
| Eagle Bay Advisors LLC | 987 | $5.00K |
| Retirement Planning Co of New England, Inc. | 400 | $2.00K |
| Capital Advisors, Ltd. LLC | 182 | $1.00K |